AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced that it has entered into a Collaboration and Exclusive Licensing ...
News Medical on MSN
Diagnostic prognostic and therapeutic relevance of PIVKA-II in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, particularly in regions with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results